Michal Gilon Ohev Zion
Chief Tech/Sci/R&D Officer bij BioCancell Therapeutics, Inc.
Profiel
Michal Gilon Ohev Zion is currently the Vice President-Research & Development at BioCancell Therapeutics, Inc. She previously worked as the Vice President-Research & Development at Anchiano Therapeutics Ltd.
Dr. Gilon Ohev Zion received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Actieve functies van Michal Gilon Ohev Zion
Bedrijven | Functie | Begin |
---|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | 01-02-2013 |
Eerdere bekende functies van Michal Gilon Ohev Zion
Bedrijven | Functie | Einde |
---|---|---|
ANCHIANO THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Michal Gilon Ohev Zion
The Hebrew University of Jerusalem | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Anchiano Therapeutics Ltd.
Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |